Status:
COMPLETED
Serum Metabolics-based Method for Diagnosing Bile Acid Diarrhoea
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Conditions:
Bile Acid Malabsorption
Bile Acid Diarrhea
Eligibility:
All Genders
18+ years
Brief Summary
Bile acid diarrhoea (BAD) is a common yet under-diagnosed and under-recognised disease. The primary symptoms are watery diarrhoea with high frequency of unpredictable bowel movements,urgency and faeca...
Detailed Description
Bile acid diarrhoea (BAD) is a common yet under-diagnosed and under-recognised disease. The primary symptoms are watery diarrhoea with high frequency of unpredictable bowel movements,urgency and faeca...
Eligibility Criteria
Inclusion
- SeHCAT referral for suspected bile acid diarrhoea
- Age ≥18 years
Exclusion
- Diabetes, except type 2 diabetes
- Nephropathy with estimated glomerular filtration rate \<30 min/1.73 m2
- Treatment with medicine that cannot be paused for 12 hours
- Hypothyroidism or hyperthyroidism, if not well regulated
- Active or recent (\<6 months since last treatment) malignant disease
- Any treatment or condition requiring acute or subacute medical or surgical intervention
- Any condition considered incompatible with trial participation by the investigators
Key Trial Info
Start Date :
May 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06548009
Start Date
May 31 2024
End Date
April 15 2025
Last Update
May 1 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg and Frederiksberg Hospital
Copenhagen, Denmark
2
Herlev Gentofte Hospital
Hellerup, Denmark
3
Hillerød Hospital
Hillerød, Denmark